特发性肺纤维化肺内缺氧测量:对照至关重要
作者认为尽管结果令人沮丧,但通过改进对照设置,缺氧聚焦成像在IPF患者中仍可能获得更有希望的结果。
要点
- Porter等的研究探索了[18F]F-MISO缺氧示踪剂在IPF中的应用,但结果不理想。
- 作者认为改进对照设置可能提升缺氧成像在IPF中的价值。
- 临床前已验证的胶原、整合素和葡萄糖代谢成像探针已进入临床试验。
核心结论
- 尽管Porter等人的结果令人沮丧,但通过使用更好的对照,缺氧聚焦成像在IPF患者中仍可能获得更 promising 的结果。
主要发现
- Porter等人探索了缺氧示踪剂[18F]氟米索硝唑([18F]F-MISO)在特发性肺纤维化(IPF)中的潜在益处。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite the discouraging results provided by Porter and co-workers, we believe that there is room for improvements, mainly by using better controls, which may ultimately lead to more promising outcomes for the use of hypoxia-focused imaging in IPF patients https://bit.ly/30Ku2AV We read with great interest the paper by Porter et al. [1] published in the October 2021 issue of the European Respiratory Journal. The authors’ aim was to explore the potential benefit of the hypoxia tracer [18F]fluoromisonidazole ([18F]F-MISO) in idiopathic pulmonary fibrosis (IPF). Given the lack of non-invasive imaging tools for the diagnosis and/or the follow-up of patients with IPF, this study appears to be an essential first step towards the personalised management of IPF patients through imaging biomarkers for early/active fibrosis. In vivo molecular imaging, in particular positron emission tomography (PET), has become a crucial tool in preclinical research, clinical trials and medical practice, especially in the field of oncology. In lung fibrosis, recent advances have been made with the aim of developing molecular imaging tools in preclinical models, a necessary step toward clinical certification [2]. Among tracers validated at the preclinical level, imaging probes targeting collagen (68Ga-CBP8 [3]), integrins ([18F]FB-A20FMDV2 [4]) and glucose metabolism ([18F]FDG [5]) have been successfully evaluated in clinical trials and may ultimately improve IPF management.
引用
- Bellaye PS, Beltramo G, Burgy O, et al. Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: a matter of control. Eur Respir J. 2022. PMID: 35086833. doi:10.1183/13993003.02711-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。